{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:03:18Z","timestamp":1792065798082,"version":"4.4.0"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003006","name":"ETH Z\u00fcrich","doi-asserted-by":"crossref","award":["4712-2"],"award-info":[{"award-number":["4712-2"]}],"id":[{"id":"10.13039\/501100003006","id-type":"DOI","asserted-by":"crossref"}]},{"name":"SNSF MHV","award":["PMPDP3_151360"],"award-info":[{"award-number":["PMPDP3_151360"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physiology & Behavior"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.physbeh.2015.06.001","type":"journal-article","created":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T10:18:16Z","timestamp":1433585896000},"page":"372-380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"PB","title":["Vagal mediation of GLP-1's effects on food intake and glycemia"],"prefix":"10.1016","volume":"152","author":[{"given":"Jean-Philippe","family":"Krieger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Langhans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.physbeh.2015.06.001_bb0005","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.physbeh.2011.12.001","article-title":"Nutrient detection by incretin hormone secreting cells","volume":"106","author":"Diakogiannaki","year":"2012","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0010","doi-asserted-by":"crossref","first-page":"978-e78","DOI":"10.1111\/j.1365-2982.2009.01317.x","article-title":"Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat","volume":"21","author":"Bucinskaite","year":"2009","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0015","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.coph.2013.08.013","article-title":"Molecular mechanisms of incretin hormone secretion","volume":"13","author":"Ezcurra","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0020","doi-asserted-by":"crossref","unstructured":"Lim, G. E. & Brubaker, P. L. Glucagon-like peptide 1 secretion by the L-cell \u2014 the view from within. Diabetes 55, S70\u2013S77.","DOI":"10.2337\/db06-S020"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0025","first-page":"1","article-title":"Glucagon-like peptide-1 7\u201336: a physiological incretin in man","author":"Kreymann","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0030","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1073\/pnas.84.10.3434","article-title":"Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line","volume":"84","author":"Drucker","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0035","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1172\/JCI112855","article-title":"Insulinotropin: glucagon-like peptide I (7\u201337) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas","volume":"79","author":"Mojsov","year":"1987","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0040","first-page":"1","article-title":"Peripheral glucagon-like peptide-1 (GLP-1) and satiation","author":"Punjabi","year":"2011","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0045","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1432-1033.1993.tb17986.x","article-title":"Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7\u201336)amide, peptide histidine methionine and is responsible for their degradation in human serum","volume":"214","author":"Mentlein","year":"1993","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0050","first-page":"952","article-title":"Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo","volume":"80","author":"Deacon","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0055","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/0014-5793(78)81210-1","article-title":"Liver dipeptidyl aminopeptidase IV hydrolyzes substance P","volume":"91","author":"Heymann","year":"1978","journal-title":"FEBS Lett."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1566-0702(00)00215-0","article-title":"Functional and chemical anatomy of the afferent vagal system","volume":"85","author":"Berthoud","year":"2000","journal-title":"Autonomic Neuroscience: Basic and Clinical"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0065","series-title":"Receptor Gene Expression of Glucagon-like Peptide-1, But not Glucose-dependent Insulinotropic Polypeptide, in Rat Nodose Ganglion Cells","first-page":"1","author":"Nakagawa","year":"2004"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0070","first-page":"E808","article-title":"Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1","volume":"271","author":"Nakabayashi","year":"1996","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0075","first-page":"1","article-title":"Glucagon-like peptide-1 evokes action potentials and increases cytosolic Ca","author":"Kakei","year":"2002","journal-title":"Autonomic Neuroscience: Basic and Clinical"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0080","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cmet.2012.06.015","article-title":"Hindbrain neurons as an essential hub in the neuroanatomically distributed control of energy balance","volume":"16","author":"Grill","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0085","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1172\/JCI990","article-title":"Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans","volume":"101","author":"Flint","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0090","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/gut.44.1.81","article-title":"Glucagon-like peptide-1: a potent regulator of food intake in humans","volume":"44","author":"Gutzwiller","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0095","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.ijo.0801627","article-title":"The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity","volume":"25","author":"Flint","year":"2001","journal-title":"Int. J. Obes. (Lond)"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0100","first-page":"R1695","article-title":"Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats","volume":"288","author":"Chelikani","year":"2005","journal-title":"AJP: Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0105","series-title":"Glucagon-like peptide-1 inhibits gastric emptying via vagalafferent-mediated central mechanisms","first-page":"1","author":"Imery\u00fcz","year":"1997"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0110","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.2337\/diabetes.50.11.2530","article-title":"Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats","volume":"50","author":"Larsen","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0115","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1053\/meta.2000.6251","article-title":"Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats","volume":"49","author":"Rodriquez de Fonseca","year":"2000","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0120","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1210\/en.2008-1045","article-title":"Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety","volume":"150","author":"Williams","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0125","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1210\/en.2005-0473","article-title":"Peripheral exendin-4 and peptide YY(3\u201336) synergistically reduce food intake through different mechanisms in mice","volume":"146","author":"Talsania","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0130","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.brainres.2005.03.011","article-title":"The inhibitory effects of peripheral administration of peptide YY3\u201336 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal\u2013brainstem\u2013hypothalamic pathway","volume":"1044","author":"Abbott","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0135","first-page":"G1117","article-title":"The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty","volume":"304","author":"Plamboeck","year":"2013","journal-title":"AJP: Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0195-6663(86)80038-1","article-title":"Specific postoperative syndromes after total and selective vagotomies in the rat","volume":"7","author":"Kraly","year":"1986","journal-title":"Appetite"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0145","first-page":"1136","article-title":"A method for selective section of vagal afferent or efferent axons in the rat","author":"Norgren","year":"1994","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0150","first-page":"R1279","article-title":"Selective vagal rhizotomies: a new dorsal surgical approach used for intestinal deafferentations","volume":"269","author":"Walls","year":"1995","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0155","first-page":"R1193","article-title":"Subdiaphragmatic vagal deafferentation fails to block feeding-suppressive effects of LPS and IL-1 beta in rats","volume":"273","author":"Schwartz","year":"1997","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0160","first-page":"n\/a-n\/a","article-title":"Vagal afferents mediate early satiation and prevent flavour avoidance learning in response to intraperitoneally infused exendin-4","author":"Labouesse","year":"2012","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0165","first-page":"R1479","article-title":"The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1","volume":"301","author":"Hayes","year":"2011","journal-title":"AJP: Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0170","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1210\/en.2011-0174","article-title":"Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4","volume":"152","author":"Kanoski","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0175","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/en.2008-1221","article-title":"Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms","volume":"150","author":"Ruttimann","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0180","article-title":"Circulating GLP-1 and CCK-8 reduce food intake by capsaicin-insensitive, nonvagal mechanisms","author":"Zhang","year":"2012","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0185","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1471-4159.2011.07563.x","article-title":"Intraportal administration of DPP-IV inhibitor regulates insulin secretion and food intake mediated by the hepatic vagal afferent nerve in rats","volume":"121","author":"Fujiwara","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0190","doi-asserted-by":"crossref","DOI":"10.1172\/JCI75276","article-title":"The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss","author":"Secher","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0195","doi-asserted-by":"crossref","DOI":"10.1172\/JCI72434","article-title":"Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect","author":"Sisley","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0200","doi-asserted-by":"crossref","first-page":"14453","DOI":"10.1523\/JNEUROSCI.3262-11.2011","article-title":"Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake","volume":"31","author":"Dossat","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0205","first-page":"E1314","article-title":"Nucleus accumbens GLP-1 receptors influence meal size and palatability","volume":"304","author":"Dossat","year":"2013","journal-title":"AJP: Endocrinology and Metabolism"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0210","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1210\/en.2011-1443","article-title":"GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake","volume":"153","author":"Alhadeff","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0215","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1523\/JNEUROSCI.6326-11.2012","article-title":"The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors","volume":"32","author":"Dickson","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0220","first-page":"E1367","article-title":"The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA\/kainate receptors","volume":"305","author":"Mietlicki-Baase","year":"2013","journal-title":"AJP: Endocrinology and Metabolism"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0225","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.coph.2013.09.004","article-title":"Enteroendocrine hormones-central effects on behavior","volume":"13","author":"Skibicka","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0230","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-1838(96)00071-9","article-title":"The hepatic vagal nerve is receptive to incretin hormone glucagon-like peptide-1, but not to glucose-dependent insulinotropic polypeptide, in the portal vein","volume":"61","author":"Nishizawa","year":"1996","journal-title":"J. Auton. Nerv. Syst."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0235","first-page":"1","article-title":"Regulatory peptides","author":"Ahr\u00e9n","year":"2014","journal-title":"Regul. Pept."},{"issue":"Suppl. 2","key":"10.1016\/j.physbeh.2015.06.001_bb0240","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.2337\/dcS13-2015","article-title":"GLP-1 effects on islets: hormonal, neuronal, or paracrine?","volume":"36","author":"Donath","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0245","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-nutr-071812-161201","article-title":"Incretins and amylin: neuroendocrine communication between the gut, pancreas, and brain in control of food intake and blood glucose","volume":"34","author":"Hayes","year":"2014","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0250","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1530\/EJE-13-0264","article-title":"Characterisation of oral and i.v. glucose handling in truncally vagotomised subjects with pyloroplasty","volume":"169","author":"Plamboeck","year":"2013","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0255","first-page":"E376","article-title":"Intraportal GLP-1 stimulates insulin secretion predominantly through the hepatoportal-pancreatic vagal reflex pathways","volume":"305","author":"Nishizawa","year":"2013","journal-title":"AJP: Endocrinology and Metabolism"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0260","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.2337\/diabetes.50.8.1720","article-title":"Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor","volume":"50","author":"Burcelin","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0265","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1210\/en.2006-0153","article-title":"Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats","volume":"148","author":"Vahl","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0270","first-page":"R1449","article-title":"Portal GLP-1 administration in rats augments the insulin response to glucose via neuronal mechanisms","volume":"279","author":"Balkan","year":"2000","journal-title":"AJP: Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0275","doi-asserted-by":"crossref","first-page":"R269","DOI":"10.1152\/ajpregu.00423.2003","article-title":"Sensory nerves contribute to insulin secretion by glucagon-like peptide-1 in mice","volume":"286","author":"Ahr\u00e9n","year":"2004","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0280","first-page":"1","article-title":"Inhibiting the cholinergic effector system of the vagus nerve reduces the insulinotropic effects of both GLP-1 and GIP","volume":"57","author":"Ahlkvist","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0285","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1172\/JCI42497","article-title":"Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice","volume":"122","author":"Lamont","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0290","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00125-005-1709-3","article-title":"Synergistic effect of portal glucose and glucagon-like peptide-1 to lower systemic glucose and stimulate counter-regulatory hormones","volume":"48","author":"Ionut","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0295","doi-asserted-by":"crossref","first-page":"G806","DOI":"10.1152\/ajpgi.00121.2005","article-title":"Insulin secretion-independent effects of GLP-1 on canine liver glucose metabolism do not involve portal vein GLP-1 receptors","volume":"289","author":"Dardevet","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0300","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s00125-012-2738-3","article-title":"Direct effect of GLP-1 infusion on endogenous glucose production in humans","volume":"56","author":"Seghieri","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0305","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/dom.12062","article-title":"Glucose-lowering effect of the DPP-4 inhibitor sitagliptin after glucose and non-glucose macronutrient ingestion in non-diabetic subjects","volume":"15","author":"Ohlsson","year":"2013","journal-title":"Diabetes Obes. Metab."},{"issue":"3","key":"10.1016\/j.physbeh.2015.06.001_bb0310","article-title":"Glucagon-like peptide 1 improved glycemic control in type 1 diabetes","volume":"3","author":"Behme","year":"2003","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0315","unstructured":"Dupr\u00e9, J. et al. Glucagon-like Peptide I Reduces Postprandial Glycemic Excursions in IDDM."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0320","doi-asserted-by":"crossref","DOI":"10.2337\/diacare.19.6.580","article-title":"Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7\u201336) amide in type I diabetic patients","author":"Creutzfeldt","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0325","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2337\/dc11-0096","article-title":"Four weeks of treatment with liraglutide reduces insulin dose without loss of glycemic control in type 1 diabetic patients with and without residual beta-cell function","volume":"34","author":"Kielgast","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0330","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2337\/dc13-1169","article-title":"Acute metabolic effects of exenatide in patients with type 1 diabetes with and without residual insulin to oral and intravenous glucose challenges","volume":"37","author":"Ghazi","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0335","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1210\/jc.2012-2332","article-title":"Vildagliptin reduces glucagon during hyperglycemia and sustains glucagon counterregulation during hypoglycemia in type 1 diabetes","volume":"97","author":"Farngren","year":"2012","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0340","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2337\/db14-1052","article-title":"Absence of glucagon and insulin action reveals a role for the GLP-1 receptor in endogenous glucose production","volume":"64","author":"Jun","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0345","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2337\/db13-0710","article-title":"Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice","volume":"63","author":"Omar","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0350","doi-asserted-by":"crossref","first-page":"E1027","DOI":"10.1152\/ajpendo.00503.2002","article-title":"Effect of intraportal glucagon-like peptide-1 on glucose metabolism in conscious dogs","volume":"284","author":"Nishizawa","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0355","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature12709","article-title":"Cooperation between brain and islet in glucose homeostasis and diabetes","volume":"503","author":"Schwartz","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0360","series-title":"F1000 Prime Reports","article-title":"Gut\u2013brain mechanisms controlling glucose homeostasis","volume":"7","author":"Jarrad","year":"2015"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0365","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2337\/db14-1671","article-title":"Hepato-incretin function of GLP-1: novel concept and target in type 1 diabetes","volume":"64","author":"Ahr\u00e9n","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0370","first-page":"1","article-title":"Putative role of neuropeptides in vagal afferent signaling","author":"de Lartigue","year":"2014","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0375","first-page":"R1011","article-title":"Brain activation following peripheral administration of the GLP-1 receptor agonist exendin-4","volume":"301","author":"Baraboi","year":"2011","journal-title":"AJP: Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0380","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1523\/JNEUROSCI.23-07-02939.2003","article-title":"Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites","volume":"23","author":"Yamamoto","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0385","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0006-8993(83)90904-6","article-title":"Synaptic interaction of vagal afferents and catecholaminergic neurons in the rat nucleus tractus solitarius","volume":"277","author":"Sumal","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0390","doi-asserted-by":"crossref","first-page":"13292","DOI":"10.1523\/JNEUROSCI.3502-07.2007","article-title":"Visceral afferents directly activate catecholamine neurons in the solitary tract nucleus","volume":"27","author":"Appleyard","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0395","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0361-9230(88)90094-9","article-title":"Olfactory and visceral projections to the paraventricular nucleus","volume":"20","author":"Guevara-Aguilar","year":"1988","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0400","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2010.03.059","article-title":"Ascending projections from the caudal visceral nucleus of the solitary tract to brain regions involved in food intake and energy expenditure","volume":"1350","author":"Rinaman","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0405","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.yfrne.2007.02.002","article-title":"Visceral sensory inputs to the endocrine hypothalamus","volume":"28","author":"Rinaman","year":"2007","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0410","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0896-6273(00)80829-6","article-title":"Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat","volume":"24","author":"Cowley","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0415","first-page":"1","article-title":"The physiological regulation of thirst and fluid intake","volume":"19","author":"McKinley","year":"2004","journal-title":"News Physiol. Sci."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0420","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1126\/science.182.4111.488","article-title":"Hypothalamic obesity: the myth of the ventromedial nucleus","volume":"182","author":"Gold","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0425","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0166-4328(86)90071-9","article-title":"Effect of paraventricular nucleus lesions on body weight, food intake and insulin levels","volume":"22","author":"Sims","year":"1986","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0430","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/hmg\/10.14.1465","article-title":"Sim1 haploinsufficiency causes hyperphagia, obesity and reduction of the paraventricular nucleus of the hypothalamus","volume":"10","author":"Michaud","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0435","unstructured":"Holder, J. L., Butte, N. F. & Zinn, A. R. Profound Obesity Associated With a Balanced Translocation That Disrupts the SIM1 Gene. hmg.oxfordjournals.org."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0440","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1210\/en.2007-1743","article-title":"Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation","volume":"149","author":"Hayes","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0445","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1523\/JNEUROSCI.09-06-01985.1989","article-title":"Ultrastructural demonstration of a gastric monosynaptic vagal circuit in the nucleus of the solitary tract in rat","volume":"9","author":"Rinaman","year":"1989","journal-title":"J. Neurosci."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0450","series-title":"Central Administration of GLP-1-(7\u201336)Amide Inhibits Food and Water Intake in Rats","first-page":"1","author":"Tang-Christensen","year":"2002"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-800101-1.00002-8","article-title":"Regulation of glucose homeostasis by GLP-1","volume":"121","author":"Nadkarni","year":"2014","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0460","first-page":"141","article-title":"Properties of solitary tract neurons receiving inputs from the sub-diaphragmatic vagus nerve","volume":"95","author":"Paton","year":"2000","journal-title":"NSC"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0465","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1523\/JNEUROSCI.5508-06.2007","article-title":"Cocaine- and amphetamine-regulated transcript: stimulation of expression in rat vagal afferent neurons by cholecystokinin and suppression by ghrelin","volume":"27","author":"de Lartigue","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0470","doi-asserted-by":"crossref","first-page":"13506","DOI":"10.1073\/pnas.96.23.13506","article-title":"Cocaine- and amphetamine-regulated transcript in the rat vagus nerve: a putative mediator of cholecystokinin-induced satiety","volume":"96","author":"Broberger","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0475","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0006-8993(02)03640-5","article-title":"CART in the dorsal vagal complex: sources of immunoreactivity and effects on Fos expression and food intake","volume":"957","author":"Zheng","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0480","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0361-9230(85)90213-8","article-title":"Immunohistochemical localization of a melanin concentrating hormone-like peptide in the rat brain","volume":"15","author":"Skofitsch","year":"1985","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0485","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0006-8993(86)90337-9","article-title":"Distribution of immunoreactive melanin-concentrating hormone in the central nervous system of the rat","volume":"373","author":"Zamir","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0490","unstructured":"Zamir, N., Skofitsch, G., Bannon, M. J. & Jacobowitz, D. M. Melanin-concentrating Hormone: Unique Peptide Neuronal System in the Rat Brain and Pituitary Gland."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0495","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1210\/en.2010-0106","article-title":"EGR1 is a target for cooperative interactions between cholecystokinin and leptin, and inhibition by ghrelin, in vagal afferent neurons","volume":"151","author":"de Lartigue","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0500","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.physbeh.2014.06.015","article-title":"Ability of GLP-1 to decrease food intake is dependent on nutritional status","volume":"135","author":"Ronveaux","year":"2014","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0505","doi-asserted-by":"crossref","DOI":"10.2337\/db12-1204","article-title":"Combination of obesity and high-fat feeding diminishes sensitivity to GLP-1R agonist, exendin-4","author":"Duca","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0510","article-title":"Decreased intestinal nutrient response in diet-induced obese rats: role of gut peptides and nutrient receptors","author":"Duca","year":"2012","journal-title":"Int. J. Obes. (Lond)"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0515","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1210\/en.2013-1447","article-title":"Circulating glucagon-like peptide-1 (GLP-1) inhibits eating in male rats by acting in the hindbrain and without inducing avoidance","volume":"155","author":"Punjabi","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0520","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.cmet.2014.01.021","article-title":"PPARg in vagal neurons regulates high-fat diet induced thermogenesis","volume":"19","author":"Liu","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0525","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.molmet.2014.06.003","article-title":"Deletion of leptin signaling in vagal afferent neurons results in hyperphagia and obesity","volume":"3","author":"de Lartigue","year":"2014","journal-title":"Mol Metab"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0530","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1172\/JCI43703","article-title":"Leptin receptor expression in hindbrain Glp-1 neurons regulates food intake and energy balance in mice","volume":"121","author":"Scott","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0535","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pain.2004.08.015","article-title":"Nociceptor-specific gene deletion using heterozygous NaV1.8-Cre recombinase mice","volume":"113","author":"Stirling","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.physbeh.2015.06.001_bb0540","doi-asserted-by":"crossref","DOI":"10.3791\/52233","article-title":"A method of nodose ganglia injection in Sprague\u2013Dawley rat","author":"Calik","year":"2014","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0545","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/erv.2256","article-title":"A systematic review of the effects of neuromodulation on eating and body weight: evidence from human and animal studies","volume":"21","author":"McClelland","year":"2013","journal-title":"Eur. Eat. Disord. Rev."},{"key":"10.1016\/j.physbeh.2015.06.001_bb0550","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrendo.2012.140","article-title":"GLP\u20101 receptor agonists for individualized treatment of type 2 diabetes mellitus","volume":"8","author":"Meier","year":"2012","journal-title":"Nat. Rev. Endocrinol."}],"container-title":["Physiology & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938415003364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938415003364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T05:08:01Z","timestamp":1566796081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031938415003364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":110,"alternative-id":["S0031938415003364"],"URL":"https:\/\/doi.org\/10.1016\/j.physbeh.2015.06.001","relation":{},"ISSN":["0031-9384"],"issn-type":[{"value":"0031-9384","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vagal mediation of GLP-1's effects on food intake and glycemia","name":"articletitle","label":"Article Title"},{"value":"Physiology & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.physbeh.2015.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}